Related Experiment Video

Updated: Feb 22, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.6K

Chromogenic analysis of FIX activity in haemophilia B patients treated with nonacog beta pegol

G Young1, M Ezban2, W H O Clausen3

  • 1Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|September 19, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.3K

Related Experiment Videos

Last Updated: Feb 22, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.6K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.5K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.3K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K

Articles linked to this work by shared authors, journal, and citation graph.

T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers.

Pediatric blood & cancer·2026

Denecimig (Mim8) prophylaxis once-every-2-weeks for hemophilia A with or without inhibitors - 26-week results from FRONTIER.

Blood advances·2026

Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study.

Blood advances·2026

Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents.

American journal of hematology·2026

New Treatment in Haemophilia: Challenges, Controversies and Uncertainties.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Understanding Contact Risks of Pediatric Physical Activity: Video Analysis to Inform Decisions for Children at Risk of Bleeding Injuries.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Patient Perspectives in Haemophilia A: Unmet Needs of Individuals Receiving Factor and Non-Factor Treatments.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Impact of Gene Therapy on the Haemophilia-Free Mind: Outcomes Before and After Valoctocogene Roxaparvovec in GENEr8-1 Trial Participants.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Artificial Intelligence and Machine Learning in the Context of Hemophilia: A Scope Review.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

A Common Language for the Multidisciplinary Team: Point-of-Care Musculoskeletal Ultrasound in Modern Haemophilia Care.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Gaps Between Prescription and Practice: Pharmacy-Based Measurement of Prophylaxis Adherence in Haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Hydrophobic Microphase Separation-Driven Polycondensation and Carbonization for the Formation of Carbonized Polymer Dots.

Angewandte Chemie (International ed. in English)·2026

Precise Modulation of CO2-to-Ethanol Conversion by Fully-Exposed Cun Clusters Induced by Dangling Bonds in Lacunary Polyoxometalate.

Advanced materials (Deerfield Beach, Fla.)·2026

Machine learning molecular dynamics for reaction rates of CO oxidation on Pt(111): Impact of site preference and oxygen coverage.

The Journal of chemical physics·2026

From Danger to Care - On the Challenges of a CDMO in the Field of Hazardous Chemistry.

Chimia·2026

Unveiling the photocatalytic degradation mechanism of methylene blue on the octahedral Cu2O(111) facets.

Chemical science·2026

Comparative Experimental Study on the Energy Efficiency of Nontraditional Activations in Catalyst-Free Processes.

ACS sustainable chemistry & engineering·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us